Chapter II definition

Chapter II. Subject Matter of Protection Subject Matter of Protection: General .......................... 4 Subject Matter of Protection: Works............................ Subject Matter of Protection: Derivative Works and Collections .................................................................... 5 6 Subject Matter Not Protected ........................................ 7
View Source
Chapter II. THE DEFENCE AND SECURITY FORCES Article 10: Principles relating to the defence and security forces 59 Article 11: Principles of organization of the defence and security forces ………………………………………..……. 60 Article 12: Missions of the defence and security forces ……… 61 Article 13: Structures of the defence and security forces …….. 63 Article 14: Composition of the defence and security forces ….. 64
View Source
Chapter II. COMPREHENSIVE REVIEW OF THE LITERATURE 5 CHAPTER IV: RECOMMENDATIONS, IMPLICATIONS, AND CONCLUSIONS 54 REFERENCES 58 Abbreviation Definition
View Source

Examples of Chapter II in a sentence

  • For fiscal years ending on or after December 25, 2015, a Single Audit is required if the subrecipient expends $750,000 or more in federal assistance during its fiscal year and must be conducted in accordance with 2 CFR Chapter I, Chapter II, Part 200, Subpart F.

  • A Single Audit is required if the subrecipient expends $750,000 or more in Federal assistance during its fiscal year and must be conducted in accordance with 2 CFR Chapter I, Chapter II, Part 200, Subpart F.

  • Except as provided above, in accordance with Title 17, Chapter II, part 248 of the Code of Federal Regulations (17 CFR 248.1 – 248.30) (“Reg S-P”), GFS will not directly, or indirectly through an affiliate, disclose any non-public personal information as defined in Reg S-P, received from a Fund to any person that is not affiliated with the Fund or with GFS and provided that any such information disclosed to an affiliate of GFS shall be under the same limitations on non-disclosure.

  • None of the transactions contemplated herein or in the other Transaction Documents (including, without limitation, the use of the proceeds from the transfer of the Collateral) will violate or result in a violation of Section 7 of the Exchange Act, or any regulations issued pursuant thereto, including, without limitation, Regulations T, U and X of the Board of Governors of the Federal Reserve System, 12 C.F.R., Chapter II.

  • For fiscal years ending on or after December 25, 2015, a Single Audit is required if the subrecipient expends $750,000 or more in Federal assistance during its fiscal year and must be conducted in accordance with 2 CFR Chapter I, Chapter II, Part 200, Subpart F.

  • None of the transactions contemplated herein or the other Transaction Documents (including, without limitation, the use of the Proceeds from the sale of the Collateral Portfolio) will violate or result in a violation of Section 7 of the Exchange Act, or any regulations issued pursuant thereto, including, without limitation, Regulations T, U and X of the Board of Governors of the Federal Reserve System, 12 C.F.R., Chapter II.

  • The Grantee shall comply with all applicable federal administrative requirements, 2 CFR Chapter I, Chapter II, Part 200, et.

  • When the requirements of 2 CFR Chapter I, Chapter II, Part 200, et.

  • Non-profit organizations that spend $750,000 or more annually in federal awards shall have a single or program-specific audit conducted for that year in accordance with 2 CFR Chapter I, Chapter II, Part 200, et.

  • Non-profit organizations that expend less than $750,000 annually in federal awards shall be exempt from an audit conducted in accordance with 2 CFR Chapter I, Chapter II, Part 200, et.


More Definitions of Chapter II

Chapter II. Review of the Literature 5 Chapter III: Methodology 13 Chapter IV: Incorporation of Reviewer Comments 21 Chapter V: Grant Proposal 36 References 58 Appendix 62 Appendix A: Assent and Consent Form 62 Appendix B: Health Insurance Portability and Accountability Act Of 1996 66 Appendix C: General Health Pre-Screening Form 67 Appendix D: Logic Model 70 Chapter I Introduction
View Source
Chapter II. Creation of an orthogonal tRNATrp/UCA/ tryptophanyl tRNA synthetase pair for incorporation of amino acid analogues in S. cevevisiae 32 Introduction 33 Experimental Procedures 40 Results and Discussion 49 An orthogonal MgentRNATrp/UCA for S. cerevisiae 49 In vivo aminoacylation assay confirms the MgentRNATrp/UCA / MgenTrpRS pair is orthogonal in S. cerevisiae 50 The MgenTrpRS specifically recognize the MgentRNATrp/UCA for the incorporation of Tryptophan to the UGA mutation on the Trp66 of ECFP 51 Optimizing the suppression efficiency of the MgentRNATrp /MgenTrpRS pair 53 Conclusion 58 Reference 76 Introduction 82 Experimental Procedures 85 Result and Discussion 99 Analysis of the screening effect of ura3-14 reporter gene 99 Site-saturation mutagenesis of MgenTrpRS 101 Library screening of MgenTrpRS mutants with activity toward 5-OH-Trp 103 Library screening of MgenTrpRS mutants with activity toward 5-MeO-Trp 106 Spectral analysis of ECFP and UAA incorporated ECFP variants 107 Confocal microscopy image analysis of cells expressing ECFP and UAA incorporated ECFP variants 108 Conclusion 108 Reference 127 Introduction 132 Experimental Procedures 135 Results 150 Cells containing the SYN1-G-Sup35 and NAC-G-Sup35 fusion proteins both showed two phenotypes 150 Aggregation state of NACp and SYN1p are different 152 [NAC+] was reversibly curable 154 Overproduction of the NAC-NR-M-GFP induced [NAC+] phenotype 156 [NAC+] was induced by cytoduction. 156 [NAC+] represents an extra-chromosomal genetic element that can be confirmed with mating and sporulation experiment 159 Discussion 160 Reference 182
View Source
Chapter II. GC-Skew Defines Distinct RNA Polymerase Pause Sites in CpG Island Promoters Chapter III: Factors Affects the Persistence of Drug-Induced Reprogramming of the Cancer Methylome Chapter IV: Orphan CpG Islands Define a Class of Highly Active Enhancers Chapter V: Therapeutic Inhibition of DNA Methylation Resets the Cancer Transcriptome Chapter VI: Discussion Chapter I: Introduction
View Source
Chapter II. Manuscript
View Source
Chapter II. Administration of the Agreement
View Source
Chapter II. ORGANISATIONAL PROVISIONS
View Source